Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
BERKELEY, Calif. and MAINZ, Germany, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (Nasdaq: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the closing of its previously announced registered direct offering with several institutional investors to purchase $5.0 million of its ordinary shares (or pre-funded warrants to purchase ordinary shares in lieu thereof) and warrants to purchase ordinary shares. The combined effective purchase price for each ordinary share (or pre-funded warrant) and associated warrant to purchase one ordinary share was $1.20.
Titan Partners Group, a division of American Capital Partners, acted as the sole placement agent for the offering.
The registered direct offering was made pursuant to an effective shelf registration statement on Form F-3 (No. 333-269091) declared effective by the U.S. Securities and Exchange Commission (the "SEC") on January 6, 2023. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering was filed with the SEC and is available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained by contacting Titan Partners Group LLC, a division of American Capital Partners, LLC, 4 World Trade, 29th floor, New York, NY 10007, by telephone at (929) 833-1246 or by email at [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Please follow us to stay up to date:
About Mainz Biomed N.V.
For media inquiries -
In the U.S.:
For investor inquiries, please contact [email protected]
Keynote Presentation by Avant
Introduction to 5G and Open-RAN
5 Good Reasons for a Single Pane of Glass